Overweight, obesity and endometrial cancer risk: Results from a systematic review and meta-analysis

International Journal of Biological Markers

Volumn 29, Issue 1, 2014, Pages

  Zhang, Yuanyuan ^a   Liu, Huaizhen ^a   Yang, Shengjie ^a   Zhang, Jinjun ^a   Qian, Liwei ^a   Chen, Xiaowen ^a  

^a Department of Cadre Endocrinology The First Affiliated Hospital Anhui Traditional Medical University   (China)

Author keywords

Endometrial cancer; Excess body weight; Meta analysis; Obesity; Overweight; Relative risk

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HORMONAL THERAPY; HUMAN; MENARCHE; MENOPAUSE; META ANALYSIS; OBESITY; SMOKING HABIT; SYSTEMATIC REVIEW; ADULT; CASE CONTROL STUDY; COMPLICATION; ENDOMETRIUM TUMOR; FEMALE; PATHOLOGY; PREGNANCY; RISK FACTOR;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBESITY; OVERWEIGHT; PREGNANCY; RISK FACTORS;

EID: 84897847172     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000047     Document Type: Article

References (57)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20: 207-25.
2. Zullo F, Palomba S, Russo T, et al. A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life. Am J Obstet Gynecol 2005; 193: 1344-52.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA Cancer J Clin 2006; 56: 106-30.
4. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95: 1276-99.
5. Di Saia PJ, Brewster WR. Hormone replacement therapy for survivors of breast and endometrial cancer. Curr Oncol Rep 2002; 4: 152-8.
6. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847-50.
7. McCourt CK, Mutch DG, Gibb RK, et al. Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecol Oncol 2007; 104: 535-9.
8. Schottenfeld D. Epidemiology of endometrial neoplasia. J Cell Biochem Suppl 1995; 23: 151-9.
9. Okamura C, Tsubono Y, Kiyoshi I, et al. Lactation and risk of endometrial cancer in Japan: a case-control study. Tohoku J Exp Med 2006; 208: 109-15.
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
11. Lukanova A, Bjor O, Kaaks R. et al. Body mass index and cancer: Results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006; 118: 458-66.
12. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134-44.
13. Chang SC, Lacey JV Jr, Brinton LA, et al. Lifetime weight history and endometrial cancer risk by health study and type of menopausal hormone use in the NIH-AARP diet. Cancer Epidemiol Biomarkers Prev 2007; 16: 723-30.
14. Canchola AJ, Chang ET, Bernstein L, et al. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control 2010; 21: 1407-16.
15. Jain MG, Rohan TE, Howe GR, et al. A cohort study of nutritional factors and endometrial cancer. Eur J Epidemiol 2000; 16: 899-905.
16. Conroy MB, Sattelmair JR, Cook NR, et al. Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control 2009; 20: 1107-15.
17. Schouten LJ, Goldbohm A, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study. J Natl Cancer Inst 2004; 96: 1635-8.
18. Xu WH, Xiang YB, Zheng W, et al. Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 2006; 35: 159-66.
19. Lu L, Risch H, Irwin ML, et al. Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer 2011; 129 (5): 1237-43.
20. Hosono S, Matsuo K, Hirose K, et al. Weight gain during adulthood and body weight at age 20 are associated with the risk of endometrial cancer in Japanese women. J Epidemiol 2011; 21: 466-73.
21. Folsom AR, Kaye SA, Potter JD, et al. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res 1989; 49: 6828-31.
22. Charneco E, Ortiz AP, Venegas-Ríos HL, et al. Clinic-based case-control study of the association between body mass index and endometrial cancer in Puerto Rican women. P R Health Sci J 2010; 29: 272-8.
23. Dal Maso L, Augustin LS, Karalis A, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004; 89: 1160-3.
24. John EM, Koo J, Horn-Ross PL. Lifetime physical activity and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 1276-83.
25. Fortuny J, Sima C, Bayuga S, et al. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 2009; 18: 1448-56.
26. Trentham-Dietz A, Nichols HB, Hampton JM, et al. Weight change and risk of endometrial cancer. Int J Epidemiol 2006; 35: 151-8.
27. Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996; 88: 1127-35.
28. Abnet CC, Freedman ND, Hollenbeck AR, et al. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008; 44: 465-71.
29. Persson C, Inoue M, Sasazuki S, et al. Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 2008; 17: 345-53.
30. Sjodahl K, Jia C, Vatten L, et al. Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomark Prev 2008; 17: 135-40.
31. Tanaka T, Nagata C, Oba S, et al. Prospective cohort study of body mass index in a dolescence and death from stomach cancer in Japan. Cancer Sci 2007; 98: 1785-9.
32. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97: 1005-8.
33. Batty GD, Barzi F, Huxley R, et al. Obesity and liver cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Cancer Epidemiol 2009; 33: 469-72.
34. Loomba R, Yang HI, Su J, et al. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin Gastroenterol Hepatol 2010; 8: 891-8.
35. Borena W, Strohmaier S, Lukanova A, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578, 700 adults. Int J Cancer 2012; 131: 193-200.
36. Kant P, Hull MA. Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 2011; 8: 224-38.
37. Olsen CM, Green AC, Whiteman DC, et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 2007; 43: 690-709.
38. Pavelka JC, Brown RS, Karlan BY, et al. Effect of obesity on survival in epithelial ovarian cancer. Cancer 2006; 107: 1520-4.
39. Skirnisdottir I, Sorbe B. Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer. Int J Gynecol Cancer 2008; 18: 345-51.
40. Skirnisdottir I, Sorbe B. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors. Acta Obstet Gynecol Scand 2010; 89: 101-7.
41. Nothlings U, Wilkens LR, Murphy SP, et al. Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control 2007; 18: 165-75.
42. Luo J, Iwasaki M, Inoue M, et al. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan-the JPHC study. Cancer Causes Control 2007; 18: 603-12.
43. Luo J, Margolis KL, Adami HO, et al. Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer 2008; 99: 527-31.
44. Johansen D, Borgstrom A, Lindkvist B, et al. Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study with in the Malmo Preventive Project. Pancreatology 2009; 9: 677-86.
45. Renehan AG, Tyson M, Egger M, et al. Body mass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies. Lancet 2008; 371: 569-78.
46. Bowers K, Albanes D, Limburg P, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006; 164: 652-64.
47. MacInnis RJ, English DR, Haydon AM, et al. Body size and composition and risk of rectal cancer (Australia). Cancer Causes Control 2006, 17: 1291-7.
48. Thygesen LC, Grønbaek M, Johansen C, et al. Prospective weight change and colon cancer risk in male US health professionals. Int J Cancer 2008; 123: 1160-5.
49. Setiawan VW, Pike MC, Kolonel LN, et al. Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol 2007; 165: 262-70.
50. Lindemann K, Vatten LJ, Ellstrom-Engh M, et al. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 2008; 98: 1582-5.
51. Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2008; 167: 607-14.
52. Friedenreich C, Cust A, Lahmann PH, et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 2007; 18: 399-413.
53. Evans DJ, Hoffmann RG, Kalkhoff RK, et al. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983; 57: 304-9.
54. Fader AN, Arriba LN, Frasure HE, et al. Endometrial cancer and obesity: epidemiology, biomarkers, Prevention and survivorship. Gynecol Oncol 2009; 114: 121-7.
55. Bakkum-Gamez JN, González-Bosquet J, Laack NN, et al. Current issues in the management of endometrial cancer. Mayo Clin Proc 2008; 83: 97-112.
56. Berstein LM, Kvatchevskaya JO, Poroshina TE, et al. Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol 2004; 130: 687-93.
57. Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 2006; 106: 2376-81.